RETRACTED: Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody

This manipulation of the peer-review process represents a clear violation of the fundamentals of peer review, our publishing policies, and publishing ethics standards. Apologies are offered to the reviewers whose identities were assumed and to the readers of the journal that this deception was not detected during the submission process.